Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma.
Kuo AM, Hassoun H, Shah U, Gordon A, Hollmann TJ, Landau HJ, Lezcano C, Mailankody S, Tan CC, Lesokhin AM, Markova A.
Kuo AM, et al.
Leuk Lymphoma. 2022 Sep;63(9):2233-2237. doi: 10.1080/10428194.2022.2068002. Epub 2022 May 9.
Leuk Lymphoma. 2022.
PMID: 35532206
Free PMC article.
No abstract available.